{"id":66656,"date":"2026-02-18T14:03:54","date_gmt":"2026-02-18T19:03:54","guid":{"rendered":"https:\/\/news2shorts.com\/index.php\/2026\/02\/18\/fda-reverses-course-and-will-review-modernas-mrna-based-flu-vaccine\/"},"modified":"2026-02-18T14:03:54","modified_gmt":"2026-02-18T19:03:54","slug":"fda-reverses-course-and-will-review-modernas-mrna-based-flu-vaccine","status":"publish","type":"post","link":"https:\/\/news2shorts.com\/index.php\/2026\/02\/18\/fda-reverses-course-and-will-review-modernas-mrna-based-flu-vaccine\/","title":{"rendered":"FDA reverses course and will review Moderna\u2019s mRNA-based flu vaccine"},"content":{"rendered":"<p>US drug regulator originally refused to consider application, fueling critics\u2019 concern about alleged \u2018anti-vaccine agenda\u2019<\/p>\n<p>The Food and Drug Administration (FDA) reversed course on Wednesday and will now review Moderna\u2019s application for the first mRNA-based flu vaccine after initially declining to consider it.<\/p>\n<p>Moderna announced that the US drug regulator will move forward with reviewing its updated flu vaccine application. The decision comes only a week after the agency <a href=\"https:\/\/www.theguardian.com\/us-news\/2026\/feb\/10\/fda-moderna-flu-vaccine\">turned down<\/a> the company\u2019s original filing, a move that had prompted criticism across the medical industry about potential changes in how the regulator is making decisions under the Trump administration.<\/p>\n<p> <a href=\"https:\/\/www.theguardian.com\/us-news\/2026\/feb\/18\/fda-modern-mrna-flu-vaccine-reversal\">Continue reading&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>US drug regulator originally refused to consider application, fueling critics\u2019 concern about alleged \u2018anti-vaccine agenda\u2019 The Food and Drug Administration (FDA) reversed course on Wednesday and will now review Moderna\u2019s application for the first mRNA-based flu vaccine after initially declining to consider it. Moderna announced that the US drug regulator will move forward with reviewing &#8230; <a title=\"FDA reverses course and will review Moderna\u2019s mRNA-based flu vaccine\" class=\"read-more\" href=\"https:\/\/news2shorts.com\/index.php\/2026\/02\/18\/fda-reverses-course-and-will-review-modernas-mrna-based-flu-vaccine\/\" aria-label=\"Read more about FDA reverses course and will review Moderna\u2019s mRNA-based flu vaccine\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-66656","post","type-post","status-publish","format-standard","hentry","category-blog"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/66656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/comments?post=66656"}],"version-history":[{"count":0,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/66656\/revisions"}],"wp:attachment":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/media?parent=66656"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/categories?post=66656"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/tags?post=66656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}